Covered recipient · General Payments record
BHUVANA MUTHUSWAMY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2025
$752.45
- Reported across 39 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $345.14 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $137.08 | 6 |
| Amgen Inc. | $70.22 | 5 |
| DEXCOM, INC. | $49.91 | 2 |
| Novo Nordisk AS | $36.97 | 2 |
| Lilly USA, LLC | $32.22 | 2 |
| Biogen, Inc. | $18.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.73 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240901525 | CMS |
| Abbott Laboratories | $21.73 | 02/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240905290 | CMS |
| Abbott Laboratories | $25.03 | 04/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240924457 | CMS |
| Abbott Laboratories | $23.02 | 05/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240939866 | CMS |
| Abbott Laboratories | $24.32 | 07/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240954615 | CMS |
| Abbott Laboratories | $21.25 | 07/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240960287 | CMS |
| Amgen Inc. | $14.55 | 05/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227170033 | CMS |
| Amgen Inc. | $13.62 | 06/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227170025 | CMS |
| Amgen Inc. | $13.50 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227170027 | CMS |
| Amgen Inc. | $14.64 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227170023 | CMS |
| Amgen Inc. | $13.91 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227170029 | CMS |
| Biogen, Inc. | $18.74 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208427758 | CMS |
| Dexcom, Inc. | $23.24 | 01/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250473373 | CMS |
| Dexcom, Inc. | $26.67 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250473375 | CMS |
| Lilly USA, LLC | $14.97 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186528173 | CMS |
| Lilly USA, LLC | $17.25 | 05/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186535475 | CMS |
| Novo Nordisk Inc | $20.65 | 08/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188271421 | CMS |
| Novo Nordisk Inc | $16.32 | 11/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188639967 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.